K Farrell1, D J Holmes-Walker. 1. Diabetes Transition Support Program, Department Diabetes and Endocrinology, Westmead Hospital, Westmead, NSW, Australia. kaye_farrell@wsahs.nsw.gov.au
Abstract
AIMS: To determine if access to mobile phone support for sick-day management is associated with reduced hospital admissions with diabetic ketoacidosis in young adults aged 15-25 with Type 1 diabetes. METHODS: This was an observational study with data collected prospectively from January 2005 to December 2008. A mobile phone support service for sick-day management began in May 2005. Data from clinic attendees (group 1), including age, sex, diabetes duration, referral age, insulin therapy delivery, clinic attendance and HbA(1c) , were compared with clinic attendees with diabetic ketosis accessing sick-day management phone support (group 2), clinic attendees not accessing phone support and admitted with diabetic ketoacidosis (group 3) and non-clinic attendees admitted with diabetic ketoacidosis (group 4). RESULTS: Age was similar in all groups. Patients in group 3 had significantly shorter duration of diabetes (6.8 ± 3.1 years) than groups 1 or 2 (10.1 and 9.8 years, respectively). Diabetes control was poor in all presentations of diabetic ketoacidosis (groups 2-4, HbA(1c) > 97 mmol/mol, > 11%) and was significantly higher than clinic attendees without ketosis (HbA(1c) 70 mmol/mol, 8.6%; P < 0.001). There was similar attendance at the clinic across all three groups, 2.9 compared with 2.4 compared with 2.1 visits/year, respectively. Thirty-one patients accessed phone support on 83 occasions for sick-day management (mean 2.7 contacts/episode); two patients progressed to admission with diabetic ketoacidosis. Diabetic ketoacidosis admission rates in the clinic population fell significantly from baseline, 0.10 to 0.05 admissions per patient per year (P < 0.05) in the third year. CONCLUSION: Mobile phone support is associated with reduced progression of ketosis to diabetic ketoacidosis in young adults despite poor diabetes control.
AIMS: To determine if access to mobile phone support for sick-day management is associated with reduced hospital admissions with diabetic ketoacidosis in young adults aged 15-25 with Type 1 diabetes. METHODS: This was an observational study with data collected prospectively from January 2005 to December 2008. A mobile phone support service for sick-day management began in May 2005. Data from clinic attendees (group 1), including age, sex, diabetes duration, referral age, insulin therapy delivery, clinic attendance and HbA(1c) , were compared with clinic attendees with diabetic ketosis accessing sick-day management phone support (group 2), clinic attendees not accessing phone support and admitted with diabetic ketoacidosis (group 3) and non-clinic attendees admitted with diabetic ketoacidosis (group 4). RESULTS: Age was similar in all groups. Patients in group 3 had significantly shorter duration of diabetes (6.8 ± 3.1 years) than groups 1 or 2 (10.1 and 9.8 years, respectively). Diabetes control was poor in all presentations of diabetic ketoacidosis (groups 2-4, HbA(1c) > 97 mmol/mol, > 11%) and was significantly higher than clinic attendees without ketosis (HbA(1c) 70 mmol/mol, 8.6%; P < 0.001). There was similar attendance at the clinic across all three groups, 2.9 compared with 2.4 compared with 2.1 visits/year, respectively. Thirty-one patients accessed phone support on 83 occasions for sick-day management (mean 2.7 contacts/episode); two patients progressed to admission with diabetic ketoacidosis. Diabetic ketoacidosis admission rates in the clinic population fell significantly from baseline, 0.10 to 0.05 admissions per patient per year (P < 0.05) in the third year. CONCLUSION: Mobile phone support is associated with reduced progression of ketosis to diabetic ketoacidosis in young adults despite poor diabetes control.
Authors: Brandi E Franklin; S Crile Crisler; Rebekah Shappley; Meri M Armour; Dana T McCommon; Robert J Ferry Journal: Diabetes Care Date: 2013-08-19 Impact factor: 19.112
Authors: Kaitlyn E Watson; Kirnvir Dhaliwal; Ella McMurtry; Teagan Donald; Nicole Lamont; Eleanor Benterud; Janice Y Kung; Sandra Robertshaw; Nancy Verdin; Kelsea M Drall; Maoliosa Donald; David J T Campbell; Kerry McBrien; Ross T Tsuyuki; Neesh Pannu; Matthew T James Journal: Kidney Med Date: 2022-05-28
Authors: Steven James; Kylie Annetts; Thuy Frakking; Marc Broadbent; John Waugh; Lin Perry; Julia Lowe; Sean Clark Journal: BMC Health Serv Res Date: 2021-07-10 Impact factor: 2.655
Authors: Rayzel Shulman; Therese A Stukel; Fiona A Miller; Alice Newman; Denis Daneman; Jonathan D Wasserman; Astrid Guttmann Journal: BMJ Open Diabetes Res Care Date: 2016-06-22
Authors: Alenka J Brooks; Philip J Smith; Richard Cohen; Paul Collins; Andrew Douds; Valda Forbes; Daniel R Gaya; Brian T Johnston; Patrick J McKiernan; Charles D Murray; Shaji Sebastian; Monica Smith; Lisa Whitley; Lesley Williams; Richard K Russell; Sara A McCartney; James O Lindsay Journal: Gut Date: 2017-02-21 Impact factor: 23.059
Authors: Phidias Rueter; Kaye Farrell; Helen Phelan; Peter Colman; Maria E Craig; Jenny Gunton; D Jane Holmes-Walker Journal: Endocrinol Diabetes Metab Date: 2021-09-09